ARCHIVES

LAK/IL-2 Extramural Trials Expanded to 20 More cancers

This article is from The Cancer Letter archive.

Vol. 14 No. 02 | January 8, 1988

Download PDF Visit The Full Archive

Related Articles

FDA News: FDA Lifts Clinical Hold On CTI’s Tosedostat

January 31, 2014

Brandt Tells NIK There May Be No Exceptions To DRG Regulations, Maybe a Few At Comprehensive Centers

June 24, 1983

Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent

January 8, 1982

NCI to Fund Research Collaboration At HMOs, Health Care Provider Networks

July 11, 1997

Newell, Fredrickson Question Ethics Of Laetrile Trials

July 22, 1977

In Brief: President Proposes $1,994 Billion For NCI;

February 10, 1995